Short-Term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway

Journal of Cellular Physiology

Volumn 229, Issue 12, 2014, Pages 2067-2076

  Filippi, Irene ^a   Morena, Emilia ^a   Aldinucci, Carlo ^a   Carraro, Fabio ^a   Sozzani, Silvano ^b   Naldini, Antonella ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; CELL HYPOXIA; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANOXIA; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; DENDRITIC CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MONOCYTES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84906707612     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24666     Document Type: Article

References (42)

1. Alvarez D, Vollmann EH, von Andrian UH. 2008. Mechanisms and consequences of dendritic cell migration. Immunity 29:325-342.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
3. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM. 2009. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29:2570-2581.
4. Blengio F, Raggi F, Pierobon D, Cappello P, Eva A, Giovarelli M, Varesio L, Bosco MC. 2013. The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells. Immunobiology 218:76-89.
5. Bonasio R, von Andrian MC. 2006. Generation, migration and function of circulating dendritic cells. Curr Opin Immunol 18:503-511.
6. Bosco MC, Varesio L. 2012. Dendritic cell reprogramming by the hypoxic environment. Immunobiology 217:1241-1249.
7. Brahimi-Horn C, Mazure N, Pouyssegur J. 2005. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17:1-9.
8. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV. 2001. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167:6140-6149.
9. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. 2005. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11:936-943.
10. Carraro F, Pucci A, Pellegrini M, Pelicci PG, Baldari CT, Naldini A. 2007. p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells. J Cell Physiol 211:439-447.
11. Chen EY, Mazure NM, Cooper JA, Giaccia AJ. 2001. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 61:2429-2433.
12. Del Prete A, Vermi W, Dander E, Otero K, Barberis L, Luini W, Bernasconi S, Sironi M, Santoro A, Garlanda C, Facchetti F, Wymann MP, Vecchi A, Hirsch E, Mantovani A, Sozzani S. 2004. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J 23:3505-3515.
13. Forster R, Braun A, Worbs T. 2012. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33:271-280.
14. Ghigo A, Morello F, Perino A, Hirsch E. 2012. Phosphoinositide 3-kinases in health and disease. Subcell Biochem 58:183-213.
15. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964.
16. Hangai-Hoger N, Cabrales P, Briceno JC, Tsai AG, Intaglietta M. 2004. Microlymphatic and tissue oxygen tension in the rat mesentery. Am J Physiol Heart Circ Physiol 286:H878-H883.
17. Huang C, Jacobson K, Schaller MD. 2004. MAP kinases and cell migration. J Cell Sci 117:4619-4628.
18. Imtiyaz HZ, Simon MC. 2010. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105-120.
19. Koh MY, Powis G. 2012. Passing the baton: the HIF switch. Trends Biochem Sci 37:364-372.
20. Kohler T, Reizis B, Johnson RS, Weighardt H, Forster I. 2012. Influence of hypoxia-inducible factor 1alpha on dendritic cell differentiation and migration. Eur J Immunol 42:1226-1236.
21. Mancino A, Schioppa T, Larghi P, Pasqualini F, Nebuloni M, Chen IH, Sozzani S, Austyn JM, Mantovani A, Sica A. 2008. Divergent effects of hypoxia on dendritic cell functions. Blood 112:3723-3734.
22. Naldini A, Filippi I, Cini E, Rodriquez M, Carraro F, Taddei M. 2012. Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells. Anticancer Agents Med Chem 12:407-413.
23. Naldini A, Filippi I, Miglietta D, Moschetta M, Giavazzi R, Carraro F. 2010. Interleukin-1beta regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1alpha. Eur J Cancer 46:3400-3408.
24. Naldini A, Morena E, Pucci A, Miglietta D, Riboldi E, Sozzani S, Carraro F. 2012. Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1alpha and lipopolysaccharide. J Cell Physiol 227:587-595.
25. Nizet V, Johnson RS. 2009. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9:609-617.
26. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD. 2007. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104:5431-5436.
27. Pouyssegur J, Dayan F, Mazure NM. 2006. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437-443.
28. Qu X, Yang MX, Kong BH, Qi L, Lam QL, Yan S, Li P, Zhang M, Lu L. 2005. Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 83:668-673.
29. Randolph GJ, Angeli V, Swartz MA. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617-628.
30. Riboldi E, Musso T, Moroni E, Urbinati C, Bernasconi S, Rusnati M, Adorini L, Presta M, Sozzani S. 2005. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol 175:2788-2792.
31. Roiniotis J, Dinh H, Masendycz P, Turner A, Elsegood CL, Scholz GM, Hamilton JA. 2009. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 182:7974-7981.
32. Semenza GL. 2001. Regulation of hypoxia-induced angiogenesis: A chaperone escorts VEGF to the dance. J Clin Invest 108:39-40.
33. Semenza GL. 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148:399-408.
34. Sitkovsky M, Lukashev D. 2005. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712-721.
35. Sozzani S. 2005. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev 16:581-592.
36. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296.
37. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21:335-376.
38. Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, Johnson RS. 2010. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes Dev 24:491-501.
39. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:1-12.
40. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL. 2000. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6:909-919.
41. Yang D, Chen Q, Gertz B, He R, Phulsuksombati M, Ye RD, Oppenheim JJ. 2002. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J Leukoc Biol 72:598-607.
42. Zhao W, Darmanin S, Fu Q, Chen J, Cui H, Wang J, Okada F, Hamada J, Hattori Y, Kondo T, Hamuro J, Asaka M, Kobayashi M. 2005. Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendritic cells. Eur J Immunol 35:3468-3477.